Peter E. Brodelius

Peter E. Brodelius

Auto-generated profile, based on publicly available information

Peter E. Brodelius

Department of Chemistry and Biomedical Sciences, Linnaeus University, Kalmar, Sweden

Research Focus & Metrics

Academic Career Length

54Years (1973-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2017 in The Plant Journal
Verified
Journal Article
Open access
PDF file
LMLuis Matías‐Hernández
Luis Matías‐Hernández
WJWeimin Jiang
Weimin Jiang
KYKe Yang
Ke Yang
KTKexuan Tang
Kexuan Tang
PBPeter E. Brodelius
Peter E. Brodelius
SPSoraya Pelaz
Soraya Pelaz
Summary: The effective anti‐malarial drug artemisinin (AN) isolated from Artemisia annua is relatively expensive due to the low AN content in the plant as AN is only synthesized within the glandular trichomes. Therefore, genetic engineering of A. annua is one of the most promising approaches for improving the yield of AN. In this work, the AaMYB1 transcription factor has been identified and characterized. When AaMYB1 is overexpressed in A. annua, either exclusively in trichomes or in the whole plant, essential AN biosynthetic genes are also overexpressed and consequently the amount of AN is significantly increased. Artemisia AaMYB1 constitutively overexpressing plants displayed a greater number of trichomes. In order to study the role of AaMYB1 on trichome development and other possibly connected biological processes, AaMYB1 was overexpressed in Arabidopsis thaliana. To support our findings in Arabidopsis thaliana, an AaMYB1 orthologue from this model plant, AtMYB61, was identified and atmyb61 mutants characterized. Both AaMYB1 and AtMYB61 affected trichome initiation, root development and stomatal aperture in A. thaliana. Molecular analyses indicated that two crucial trichome activator genes are misexpressed in atmyb61 mutant plants and in plants overexpressing AaMYB1. Furthermore, AaMYB1 and AtMYB61 are also essential for gibberellin (GA) biosynthesis and degradation in both species by positively affecting the expression of the enzymes that convert GA9 into the bioactive GA4 as well as the enzymes involved in the degradation of GA4. Overall, these results identify AaMYB1/AtMYB61 as a key component of the molecular network that connects important biosynthetic processes, and reveal its potential value for AN production through genetic engineering.

1 June 2009 in Phytochemistry
Verified
Journal Article
Closed access
MOMikael E. Olsson
Mikael E. Olsson
LOLinda M. Olofsson
Linda M. Olofsson
ALAnn-Louise Lindahl
Ann-Louise Lindahl
ALAnneli Lundgren
Anneli Lundgren
MBMaria Brodelius
Maria Brodelius
PBPeter E. Brodelius
Peter E. Brodelius

9 March 2011 in BMC Plant Biology
Verified
Journal Article
Open access
PDF file
LOLinda Olofsson
Linda Olofsson
AEAlexander Engström
Alexander Engström
ALAnneli Lundgren
Anneli Lundgren
PBPeter E Brodelius
Peter E Brodelius
Background: Recently, Artemisia annua L. (annual or sweet wormwood) has received increasing attention due to the fact that the plant produces the sesquiterpenoid endoperoxide artemisinin, which today is widely used for treatment of malaria. The plant produces relatively small amounts of artemisinin and a worldwide shortage of the drug has led to intense research in order to increase the yield of artemisinin. In order to improve our understanding of terpene metabolism in the plant and to evaluate the competition for precursors, which may influence the yield of artemisinin, we have used qPCR to estimate the expression of 14 genes of terpene metabolism in different tissues. Results: The four genes of the artemisinin biosynthetic pathway (amorpha-4,11-diene synthase, amorphadiene-12-hydroxylase, artemisinic aldehyde ∆11(13) reductase and aldehyde dehydrogenase 1) showed remarkably higher expression (between ~40- to ~500-fold) in flower buds and young leaves compared to other tissues (old leaves, stems, roots, hairy root cultures). Further, dihydroartemisinic aldehyde reductase showed a very high expression only in hairy root cultures. Germacrene A and caryophyllene synthase were mostly expressed in young leaves and flower buds while epi-cedrol synthase was highly expressed in old leaves. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase exhibited lower expression in old leaves compared to other tissues. Farnesyldiphosphate synthase, squalene synthase, and 1-deoxy-D-xylulose-5-phosphate reductoisomerase showed only modest variation in expression in the different tissues, while expression of 1-deoxy-D-xylulose-5-phosphate synthase was 7-8-fold higher in flower buds and young leaves compared to old leaves. Conclusions: Four genes of artemisinin biosynthesis were highly expressed in flower buds and young leaves (tissues showing a high density of glandular trichomes). The expression of dihydroartemisinic aldehyde reductase has been suggested to have a negative effect on artemisinin production through reduction of dihydroartemisinic aldehyde to dihydroartemisinic alcohol. However, our results show that this enzyme is expressed only at low levels in tissues producing artemisinin and consequently its effect on artemisinin production may be limited. Finally, squalene synthase but not other sesquiterpene synthases appears to be a significant competitor for farnesyl diphosphate in artemisinin-producing tissues.

29 December 1980 in FEBS Letters
Verified
Journal Article
Closed access
PBPeter Brodelius
Peter Brodelius
KNKjell Nilsson
Kjell Nilsson

1 May 2005 in Phytochemistry
Verified
Journal Article
Closed access
SPSarah Picaud
Sarah Picaud
MBMaria Brodelius
Maria Brodelius
PBPeter E. Brodelius
Peter E. Brodelius

1 June 2014 in Phytochemistry
Verified
Journal Article
Closed access
JHJunli Han
Junli Han
HWHongzhen Wang
Hongzhen Wang
ALAnneli Lundgren
Anneli Lundgren
PBPeter E. Brodelius
Peter E. Brodelius